Strong growth in APAC throughout the year, improving sales in EMEA and Americas in H2
Adjusted profit before tax up by 146% to £119.7m
Fit for the Future initiative reduced our cost base and drove productivity improvements
Return on sales increased to 21% (2020: 10%), with 25% in H2
End of period cash rises to £215.0m
Strong trading performance and reduced capital expenditure and dividends
Formal sale process, which commenced in March 2021, was concluded in July with no suitable offers
Slide 2
Key metrics
2021
2020
Change
£m
£m
%
Revenue
565.6
510.2
11%
Adjusted profit
119.7
48.6
146%
before tax
Statutory profit
139.4
3.2
4,256%
before tax
End of period cash
215.0
120.4
and bank deposits
Regional revenue
2021
2020
Change
£m
£m
%
APAC
274.8
227.7
21%
EMEA
169.1
167.2
1%
Americas
121.7
115.3
5%
Transforming Tomorrow Together
We make it possible to create the products, materials and therapies that will
define our world in the decades to come and touch billions of lives
Manufacturing technologies
Analytical instruments and medical devices
(formerly Metrology)
(formerly Healthcare)
Slide 3
Manufacturing technologies
Analytical instruments and medical devices
2021
2020
Change
£m
£m
%
Revenue
526.2
475.2
11%
Adjusted operating profit
112.6
50.3
124%
Record demand for encoders, driven by booming semiconductor and electronics capital investment
Rising sales of flexible gauging and machine tool products, especially in consumer electronics sector
Lower AM sales as expected following restructuring
Slide 4
2021
2020
Change
£m
£m
%
Revenue
39.4
35.0
12%
Adjusted operating profit
5.9
1.4
321%
General recovery in Spectroscopy investment and increasing adoption of the Virsa™ Raman Analyzer
Growth in Neurological products, as we support large pharma customers with clinical trials using our unique drug delivery technology
Market development - semiconductor and electronics
Boom in capex to tackle supply shortages
Demand for consumer electronics increased during the pandemic
Ongoing growth in 5G, 5nm chips, EVs all fuelling demand for semiconductors
Major producers building and equipping new fabs to meet rising demand
Renishaw's market position
Our position encoder and calibration systems are used throughout the supply chain
Current challenge is keeping up with customer demand
Slide 5
This is an excerpt of the original content. To continue reading it, access the original document here.
Attachments
Original document
Permalink
Disclaimer
Renishaw plc published this content on 21 October 2021 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 21 October 2021 18:23:08 UTC.
Renishaw plc is a United Kingdom-based supplier of measuring systems and production systems. The principal activities of the Company are the design, manufacture, sale, distribution and service of manufacturing technologies products and services, and analytical instruments and medical devices. The Company operates through two segments: manufacturing technologies, and analytical instruments and medical devices. The manufacturing technologies segment consists of four areas: industrial metrology, additive manufacturing, position measurement and the new industrial automation line. The analytical instruments and medical devices segment consist of spectroscopy and neurological, where it supplies its customers with technologies to improve materials analysis and neurological therapies. Its products include CMM probes, software, and retrofits; equator gauging system; interferometric laser encoders; probing and tool measurement systems for machine tools, and others.
RENISHAW PLC 
